Buy or sell Miromatrix Medical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Miromatrix Medical Stock

Miromatrix Medical's technology aims to develop fully-biological replacement organs for the human body.

About Miromatrix Medical Stock

The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biomesh for hernia repair and breast reconstruction – scientists around the globe are working with the Company’s technology and are taking the first steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. It is our intent to retain laser focus on our Biomesh development program internally, while partnering with the best among those external groups already working with our technology in order to utilize this pre-existing expertise to develop individual products in the most efficacious, cost-effective and timely way possible.

Funding History

December 2011$2.0M
July 2012$5.3M
October 2013$5.0M
May 2014$6.1M
August 2015$23.3M
July 2018$15.7M

Management

President and CEO

Robert Cohen

Founder

Doris Taylor

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Miromatrix Medical or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo